Robert Ticktin serves as Executive at EPIRUS Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert Ticktin has executed 4 insider transactions totaling $35.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 1, 2025 involved selling 23,151 shares valued at $24.5K.
Robert Ticktin currently holds 98,695 shares of EPIRUS Biopharmaceuticals, Inc. (EPRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Ticktin has been a net seller of EPRS stock. They have purchased $11.2K and sold $24.5K worth of shares.
Robert Ticktin's most recent insider trade was on Jul 1, 2025, when they sold 23,151 shares at $1.06 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 27, 2016 | EPRS | $0 | Option Exercise | 949 | $N/A | Discretionary |
| Dec 21, 2015 | EPRS | $11.2K | Purchase | 3,000 | $3.72 | Discretionary |